For Esperion Therapeutics, 2024 has marked a pivotal transformation in its mission to combat cardiovascular disease. | ...

A recent study published in the Journal of Translational Internal Medicine reveals insights into the broader impact of ...

Deaths from cardiovascular disease have surged among adults ages 25 to 64 living in rural areas, a new study shows.

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Among the common but lesser-known consequences of intimate partner violence is a heightened risk for cardiovascular disease.

A new, multinational study has revealed that the shape of the human heart, influenced by genetic factors, could serve as a ...

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

Like a fire alarm sending signals to evacuate a smoky building, the immune system has internal guards to help the body sense ...

Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Risk for clinical depression is increased in patients with cardiovascular disease that have insufficient sleep. Insufficient sleep is associated with risk for clinical depression in patients with ...

Salk scientists have tracked the flow of trans fats using mouse models to describe the molecular mechanisms that cause trans ...